SCHEMBL4876009

SCHEMBL4876009

C[Si](C)(C)OC(C#N)c1ccc(-n2ccnc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ENPP2 Q13822 1/20 0.44
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
NOTUM Q6P988 1/20 0.44
CYP3A4 P08684 4/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP19A1 P11511 1/20 0.43
HTT P42858 1/20 0.43
BAZ2B Q9UIF8 1/20 0.42
MEN1 O00255 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364392 0.78 LMNA (0.50) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL19717446 0.75 CYP3A4 (0.36) CYP3A4CYP2C19CYP19A1
SCHEMBL801703 0.72 NOTUM (0.63) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL7089384 0.72 ALDH1A1 (0.39) LMNAMAPTCYP19A1HTTKMT2A
SCHEMBL5633600 0.71 ALDH1A1 (0.43) LMNAMAPTCYP3A4CYP1A2CYP2C19
SCHEMBL2532397 0.71 LMNA (0.78) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL4671383 0.71 ALDH1A1 (0.40) LMNAMAPTCYP1A2CYP2C9CYP2C19
SCHEMBL7575011 0.71 LMNA (0.39) LMNACYP3A4CYP1A2CYP2C19HTT
SCHEMBL16094149 0.71 CYP19A1 (0.41) NOTUMCYP3A4CYP2C19CYP19A1HTT
SCHEMBL4811110 0.71 KDM4E (0.38) MAPTCYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed
WO-2008004117-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER PRODUCTS INC. (US) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PDE5A, PDE3B, PDE12 LMNA 3434/4885MAPT 964/4885ENPP2 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.